Authors:
Catella-Lawson, F
Kapoor, S
Moretti, D
De Marco, S
Vigilante, GJ
Cucchiara, AJ
Ramsey, KE
Combe, S
Rocca, B
Theroux, P
Fitzgerald, GA
Citation: F. Catella-lawson et al., Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery disease, AM J CARD, 88(3), 2001, pp. 236-242
Authors:
Crofford, LJ
Oates, JC
McCune, WJ
Gupta, S
Kaplan, MJ
Catella-Lawson, F
Morrow, JD
McDonagh, KT
Schmaier, AH
Citation: Lj. Crofford et al., Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors - A report of four cases, ARTH RHEUM, 43(8), 2000, pp. 1891-1896
Authors:
Reilly, MP
Moran, N
Meagher, E
Delanty, N
Cucchiara, AE
Lawson, JA
Catella-Lawson, F
Citation: Mp. Reilly et al., A randomized, placebo-controlled, crossover study of E5510 and aspirin in healthy volunteers, J CARDIO PH, 33(1), 1999, pp. 12-18
Authors:
McAdam, BF
Catella-Lawson, F
Mardini, IA
Kapoor, S
Lawson, JA
FitzGerald, GA
Citation: Bf. Mcadam et al., Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The humanpharmacology of a selective inhibitor of COX-2 (vol 96, pg 272, 1999), P NAS US, 96(10), 1999, pp. 5890-5890
Authors:
McAdam, BF
Catella-Lawson, F
Mardini, IA
Kapoor, S
Lawson, JA
FitzGerald, GA
Citation: Bf. Mcadam et al., Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The humanpharmacology of a selective inhibitor of COX-2, P NAS US, 96(1), 1999, pp. 272-277
Authors:
Catella-Lawson, F
McAdam, B
Morrison, BW
Kapoor, S
Kujubu, D
Antes, L
Lasseter, KC
Quan, H
Gertz, BJ
Fitzgerald, GA
Citation: F. Catella-lawson et al., Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids, J PHARM EXP, 289(2), 1999, pp. 735-741